Clinical Trials Browser

Interventional × Recurrence × Clinical Trials, Phase II as Topic × Clear all

NCT05958121 2025-11-18

IMA402 T Cell-Engaging Receptor Molecule (TCER®) in Recurrent and/or Refractory Solid Tumors

Phase 1/2 Recruiting

Neoplasms, Recurrence

NCT03683277 2025-02-19

IFM2014-01

Phase 2 Terminated

Multiple Myeloma, Recurrence, Genetic Diseases, Inborn

NCT01572519 2020-11-20

A Study of JNJ-40346527 in Patients With Relapsed or Refractory Hodgkin Lymphoma

Phase 1 Completed

Hodgkin Disease, Recurrence